1. Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Republic of (South);
2. Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands;
3. Institut Claudius Régaud, Toulouse, France;
4. Rambam Health Care Campus, Haifa, Israel;
5. Institut Bergonié, Bordeaux, France;
6. Sheba Medical Center, Ramat-Gan, Israel;
7. N.N. Blokhin NMRCO, Moscow, Russian Federation;
8. The University of Texas MD Anderson Cancer Center, Houston, TX;
9. Merck & Co., Inc., Kenilworth, NJ;
10. Département d’Innovation Thérapeutique et d’Essais Précoces, Gustave Roussy, Villejuif, France;